Sleep and aging: 2. Management of sleep disorders in older people

被引:58
作者
Wolkove, Norman
Elkholy, Osama
Baltzan, Marc
Palayew, Mark
机构
[1] Mt Sinai Hosp Ctr, Sleep Clin, Montreal, PQ H4W 1S7, Canada
[2] McGill Univ, Fac Med, Montreal, PQ, Canada
关键词
D O I
10.1503/cmaj.070335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment of sleep-related illness in older patients must be undertaken with an appreciation of the physiologic changes associated with aging. Insomnia is common among older people. When it occurs secondary to another medical condition, treatment of the underlying disorder is imperative. Benzodiazepines, although potentially effective, must be used with care and in conservative doses. Daytime sedation, a common side effect, may limit use of benzodiazepines. Newer non-benzodiazepine drugs appear to be promising. Rapid eye movement (REM) sleep behaviour disorder can be treated with clonazepam, levodopa-carbidopa or newer dopaminergic agents such as pramipexole. Sleep hygiene is important to patients with narcolepsy. Excessive daytime sleepiness can be treated with central stimulants; cataplexy may be improved with an antidepressant. Restless legs syndrome and periodic leg-movement disorder are treated with benzodiazepines or dopaminergic agents such as levodopa-carbidopa and, more recently, newer dopamine agonists. Treatment of obstructive sleep apnea includes weight reduction and proper sleep positioning (on one's side), but may frequently necessitate the use of a continuous positive air-pressure (CPAP) device. When used regularly, CPAP machines are very effective in reducing daytime fatigue and the sequelae of untreated obstructive sleep apnea.
引用
收藏
页码:1449 / 1454
页数:6
相关论文
共 49 条
[1]  
Barkin R L, 2000, Am J Ther, V7, P205, DOI 10.1097/00045391-200007030-00008
[2]   Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy [J].
Black, J ;
Emsellem, H ;
Chase, C ;
Feldman, N ;
Hagaman, M ;
Hayduk, R ;
Lankford, D ;
Kathawalla, S ;
Marmion, L ;
Mitler, M ;
Pascualy, R ;
Sahota, P ;
Scharf, M ;
Scrima, L ;
Swick, T ;
Ware, J .
SLEEP MEDICINE, 2004, 5 (02) :119-123
[3]  
Black J, 2003, SLEEP, V26, P31
[4]   Ropinirole in the treatment of patients with restless legs syndrome: A US-based randomized, double-blind, placebo-controlled clinical trial [J].
Bogan, RK ;
Fry, JM ;
Schmidt, MH ;
Carson, SW ;
Ritchie, SY .
MAYO CLINIC PROCEEDINGS, 2006, 81 (01) :17-27
[5]   Continuous positive airway pressure for central sleep apnea and heart failure [J].
Bradley, TD ;
Logan, AG ;
Kimoff, RJ ;
Sériès, F ;
Morrison, D ;
Ferguson, K ;
Belenkie, I ;
Pfeifer, M ;
Fleetham, J ;
Hanly, P ;
Smilovitch, M ;
Tomlinson, G ;
Floras, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (19) :2025-2033
[6]   Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis [J].
Buscemi, N ;
Vandermeer, B ;
Hooton, N ;
Pandya, R ;
Tjosvold, L ;
Hartling, L ;
Vohra, S ;
Klassen, TP ;
Baker, G .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7538) :385-388C
[7]   The efficacy and safety of exogenous melatonin for primary sleep disorders - A meta-analysis [J].
Buscemi, N ;
Vandermeer, B ;
Hooton, N ;
Pandya, R ;
Tjosvold, L ;
Hartling, L ;
Baker, G ;
Klassen, TP ;
Vohra, S .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (12) :1151-1158
[8]   ALLEVIATION OF SLEEP MAINTENANCE INSOMNIA WITH TIMED EXPOSURE TO BRIGHT LIGHT [J].
CAMPBELL, SS ;
DAWSON, D ;
ANDERSON, MW .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1993, 41 (08) :829-836
[9]   Restless legs syndrome - Treatment with dopaminergic agents [J].
Comella, CL .
NEUROLOGY, 2002, 58 (04) :S87-S92
[10]  
Cotroneo A, 2004, ARCH GERONTOL GERIAT, P93